AbbVie ABBV
NYSE ABBV
$263.90 -0.10 (-0.04%)
At close: Sep 18, 2026 · 4:00 PM EDT

AbbVie (ABBV) Goodwill & Intangibles (2012 - 2026)

AbbVie's (ABBV) quarterly Goodwill & Intangibles came in at $84.7 billion in Q2 2026, down 8.64% year-over-year from $92.7 billion in Q2 2025, and down 2.06% quarter-over-quarter from $86.4 billion in Q1 2026.

Analysis

AbbVie (ABBV) Goodwill & Intangibles (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported Goodwill & Intangibles for 15 consecutive years, with $84.7 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 8.64% year-over-year to $84.7 billion in Q2 2026; TTM through Jun 2026 was $84.7 billion, a 8.64% decrease from a year earlier, with the FY2025 full-year figure at $88.3 billion, down 7.1% from the prior year.
  • Goodwill & Intangibles was $84.7 billion for Q2 2026 at AbbVie, down from $86.4 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $106.3 billion in Q1 2022 and troughed at $84.7 billion in Q2 2026.
  • A 5-year average of $94.6 billion and a median of $94.4 billion in 2024 frame the typical range for Goodwill & Intangibles.
  • Across the five-year window, Goodwill & Intangibles climbed 12.4% in 2024 and fell 11.77% in 2025, its largest moves.
  • Over 5 years, Goodwill & Intangibles stood at $99.6 billion in 2022, then decreased by 11.74% to $87.9 billion in 2023, then increased by 8.1% to $95.0 billion in 2024, then decreased by 7.1% to $88.3 billion in 2025, then retreated by 4.1% to $84.7 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $84.7 billion (Q2 2026), $86.4 billion (Q1 2026), and $88.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.66 Bn
Mar 31, 2026 86.44 Bn
Dec 31, 2025 88.28 Bn
Sep 30, 2025 89.94 Bn
Jun 30, 2025 92.67 Bn
Mar 31, 2025 93.77 Bn
Dec 31, 2024 95.02 Bn
Sep 30, 2024 101.94 Bn
Jun 30, 2024 93.63 Bn
Mar 31, 2024 95.65 Bn
Dec 31, 2023 87.90 Bn
Sep 30, 2023 90.69 Bn
Jun 30, 2023 95.09 Bn
Mar 31, 2023 97.07 Bn
Dec 31, 2022 99.60 Bn
Sep 30, 2022 100.45 Bn
Jun 30, 2022 103.85 Bn
Mar 31, 2022 106.28 Bn
Dec 31, 2021 108.33 Bn
Sep 30, 2021 109.75 Bn